Jain Global LLC Eye Point Pharmaceuticals, Inc. Transaction History
Jain Global LLC
- $7.88 Billion
- Q1 2025
A detailed history of Jain Global LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Jain Global LLC holds 31,380 shares of EYPT stock, worth $180,435. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,380Holding current value
$180,435% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EYPT
# of Institutions
165Shares Held
71.5MCall Options Held
232KPut Options Held
207K-
Cormorant Asset Management, LP Boston, MA8.33MShares$47.9 Million4.79% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$39.1 Million1.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.2MShares$35.7 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA4.15MShares$23.9 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$23.5 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $196M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...